Cutaneous T-Cell Lymphoma Study

The purpose of this study is to assess the effectiveness and safety of a topical (applied to the skin) gel in the treatment of cutaneous T-cell lymphoma (CTCL) when compared to a placebo (inactive substance).

People who have a clinical diagnosis of CTCL and are aged 18 and older may qualify to receive study drug at no cost.  There is no cost to participate, and participants will be reimbursed $55.00 - $110.00 per visit for transportation fees.

In order to qualify, participants must have:

  • Stage IA, IB, or IIA CTCL.
  • At least three distinct patches, plaques, or tumors on their skin.

Participants will be asked to visit the study center about 13 times over a period of about 40 weeks.

Call the study centre near you, or register now.

Learn more about
Cutaneous T-Cell Lymphoma
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Similar Studies

  • At this time there are no other studies for this condition. Please register to be contacted about upcoming studies for this condition.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more